According to Applied BioCode, the CE Certification for the BioCode-1000 Analyzer proves that the anlyzer has met all relevant European Union consumer safety requirements.

The CE Mark will allow Applied BioCode to market its products in the European Economic Area, in addition to many other international markets who are non-members of the European Union.

Applied BioCode claimed that the BioCode-1000 Analyzer, together with Barcoded Magnetic Beads (BMB) multiplex technology, provides a flexible system, intended for research use only, but with a wide variety of biological applications to assist those focused on molecular diagnostics, gene mutation analysis, drug resistance genotyping, and pharmaceutical drug discovery.

The BioCode-1000 Analyzer is a rapid, simple, and robust imaging system for use with a 96-well microplate format. Applied BioCode’s system is used to detect from 2 to 128-plex Nucleic Acid or Protein targets in individual microwells. The CE certified BMB multiplex platform can scan a 96-well microplate, decode BMB barcodes, measure label fluorescence, and displays up to 128 results per microwell in only 40 seconds.

The system is extremely sensitive (0.5 fm/ml GAPDH (DNA) and 1.0 pg/ml IL-2 (protein) with PE label) and has been used for a variety of test panels. The Barcoded Magnetic Beads multiplexed platform is robust and easy to use, because no complicated laser or flow cytometer is needed.

The Barcoded Magnetic Beads offer high contrast digital barcodes, enabling accurate decoding. Applied BioCode’s multiplex system simplifies the molecular diagnostic testings of multiplex assays while offering high throughput, high accuracy and affordability.